Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 52
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Ann Oncol ; 28(2): 254-269, 2017 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-28426098

RESUMEN

Background: Although the role of epigenetic abnormalities has been studied for several years in cancer genesis and development, epigenetic-targeting drugs have historically failed to demonstrate efficacy in solid malignancies. However, successful targeting of chromatin remodeling deficiencies, histone writers and histone reader alterations has been achieved very recently using biomarker-driven and mechanism-based approaches. Epigenetic targeting is now one of the most active areas in drug development and could represent novel therapeutic opportunity for up to 25% of all solid tumors. Material and methods: We reviewed preclinical and clinical studies that described epigenetic oncogenic addictions, synthetic lethal relationships or epigenetic antagonisms in chromatin regulators. Experimental approaches, their clinical relevance and applicability, as well as corresponding on-going studies are described. Results: The most successful approaches that have been clinically validated so far include the targeting of the BRD4-NUT fusion transcript in NUT-midline carcinoma by BET (Bromodomain Extra-Terminal) inhibitors, and the use of EZH2 (Enhancer of Zest Homolog 2) inhibitors in SMARCB1-deficient malignant rhabdoid tumors and SMARCA4-deficient ovarian small cell carcinomas. Clinical validation is still required for other synthetic lethal relationships or epigenetic antagonisms, including those described between EZH2 inhibitors and deficiencies in components of the Polycomb or SWI/SNF chromatin-remodeling complexes (including BAP1, ARID1A and PBRM1 subunits), as well as between the CREBBP and EP300 histone acetylases. Further, interplays between epigenetic modifiers and non-epigenetic cellular processes might be therapeutically exploited, and combinatorial strategies could be envisioned to overcome resistance or to sensitize cells to already approved drugs. Conclusion: Epigenetic-targeting drugs have historically failed proving efficacy in solid malignancies when used broadly, but novel mechanism-based approaches in molecularly selected patient populations have facilitated recent successes in proof-of-concept studies in solid tumors. Appropriate clinical trial design and molecular patient selection will be key for the success of epigenetic modifiers in solid tumours.


Asunto(s)
Epigénesis Genética/efectos de los fármacos , Neoplasias/tratamiento farmacológico , Cromatina/genética , Ensamble y Desensamble de Cromatina , Regulación Neoplásica de la Expresión Génica , Humanos , Terapia Molecular Dirigida , Neoplasias/genética , Dependencia del Oncogén , Medicina de Precisión , Mutaciones Letales Sintéticas
2.
Methods Enzymol ; 573: 97-117, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27372750

RESUMEN

Histone chaperones-key actors in the dynamic organization of chromatin-interact with the various histone variants to ensure their transfer in and out of chromatin. In vitro chromatin assembly assays and isolation of protein complexes using tagged histone variants provided first clues concerning their binding specificities and mode of action. Here, we describe an in vivo method using SNAP-tag-based imaging to assess the de novo deposition of histones and the role of histone chaperones. This method exploits cells expressing SNAP-tagged histones combined with individual cell imaging to visualize directly de novo histone deposition in vivo. We show how, by combining this method with siRNA-based depletion, we could assess the function of two distinct histone chaperones. For this, we provide the details of the method as applied in two examples to characterize the function of the histone chaperones CAF-1 and HIRA. In both cases, we document the impact of their depletion on the de novo deposition of the histone variants H3.1 and H3.3, first in a normal context and second in response to DNA damage. We discuss how this cellular assay offers means to define in a systematic manner the function of any chosen chaperone with respect to the deposition of a given histone variant.


Asunto(s)
Chaperonas de Histonas/metabolismo , Histonas/metabolismo , O(6)-Metilguanina-ADN Metiltransferasa/genética , Animales , Técnicas de Cultivo de Célula/métodos , Cromatina/metabolismo , Daño del ADN , Colorantes Fluorescentes/análisis , Colorantes Fluorescentes/metabolismo , Guanina/análogos & derivados , Guanina/metabolismo , Chaperonas de Histonas/análisis , Chaperonas de Histonas/genética , Histonas/análisis , Histonas/genética , Humanos , Microscopía Fluorescente/métodos , Mutación , O(6)-Metilguanina-ADN Metiltransferasa/análisis , O(6)-Metilguanina-ADN Metiltransferasa/metabolismo , Imagen Óptica/métodos , Proteínas Recombinantes de Fusión/análisis , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo
3.
Artículo en Inglés | MEDLINE | ID: mdl-21209390

RESUMEN

How a nuclear domain is formed at specific chromatin loci and maintained throughout multiple cellular divisions is a central question in the field of nuclear organization. Recent efforts have concentrated on understanding how a domain is set during development in a particular cell lineage and then how DNA replication and repair in interphase as well as chromosome dynamics in mitosis deal with chromatin states at specific loci to propagate functional organization. In the latter case, for each of these events, one must not only evaluate the impact in terms of the extent of the disruption and/or modification of chromatin but also determine how and when proper organization can be restored thereafter. Using heterochromatin at mouse pericentromeres as a model, we present how important advances have been made that open avenues for understanding mechanisms involved in de novo heterochromatin formation and its duplication during replication.


Asunto(s)
Centrómero/metabolismo , Replicación del ADN/genética , Duplicación de Gen/genética , Heterocromatina/metabolismo , Modelos Genéticos , Animales , Desarrollo Embrionario/genética , Ratones , Células 3T3 NIH , Fase S
5.
J Cell Sci ; 114(Pt 15): 2711-2, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11683405
6.
J Cell Sci ; 114(Pt 13): 2483-9, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11559756

RESUMEN

Phosphorylation of RNA polymerase II largest subunit on its C-terminal domain (CTD) heptapeptide repeats has been shown to play a key role in the regulation of mRNA synthesis and processing. In many higher metazoans, early embryos do not synthesise mRNAs during the first cell cycles following fertilisation. Transcription resumes and becomes an absolute requirement for development after several cell cycles characteristic of each species. Therefore, CTD phosphorylation has been investigated during early development of the African clawed-frog Xenopus laevis. Fertilisation is shown to trigger an abrupt dephosphorylation of the CTD. Phosphorylation of the CTD resumes concurrently with the mid-blastula transition (MBT). Both are advanced with polyspermy and increased temperatures; they do not occur when replication is impaired with aphidicolin. In Xenopus laevis somatic cells, a set of monoclonal antibodies defined distinct phosphoepitopes on the CTD. Two of them were absent before the MBT indicating that the CTD lacks the phosphorylation at the serine-2 position of the heptapeptide. The possible contribution of RNA polymerase II phosphorylation to the developmental-regulation of maternal mRNA processing in embryos is discussed.


Asunto(s)
ARN Polimerasas Dirigidas por ADN/metabolismo , Regulación del Desarrollo de la Expresión Génica , Xenopus laevis/embriología , Animales , Blastocisto/metabolismo , Fosforilación
7.
J Cell Sci ; 114(Pt 17): 3074, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11590233
8.
Exp Cell Res ; 269(1): 23-34, 2001 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-11525636

RESUMEN

The nuclear functions in erythrocytes are almost completely extinct. There is no RNA polymerase I transcription, although a remnant nucleolar structure is still present. The remnant nucleolus of Xenopus laevis erythrocytes maintains a morphologically organized structure, nearly exclusively fibrillar. In this inactive nucleolar remnant, we revealed the presence of a modified form of transcription factor UBF. Several proteins of the processing machinery such as fibrillarin, nucleolin and B23/NO38, snoRNAs U3 and U8, and partially processed preribosomal RNAs colocalized in these remnant structures. Attempts to reprogram these erythrocyte nuclei in Xenopus egg extract showed that import of several nucleolar proteins was induced while the nucleolar remnant was disorganized. UBF became abundant and showed a necklace-like distribution on the decondensed ribosomal genes. Fibrillarin, nucleolin, and snoRNAs U3 and U8, also largely imported from the extract, were associated in large prenuclear bodies scattered in the nucleoplasm. B23/NO38 was present in different small bodies formed only in the most decondensed nuclei. In these remodeled erythrocyte nuclei, there was no imported preribosomal RNA and the initial presence of a residual nucleolar structure containing several partners of ribosome biogenesis was not sufficient to promote reassembly of newly imported nucleolar machineries. These nuclei, which reproduce the early events of nucleogenesis are also transcriptionally silent and thus compare to the early embryonic nuclei of Xenopus laevis.


Asunto(s)
Extractos Celulares/farmacología , Nucléolo Celular/metabolismo , Eritrocitos/metabolismo , Oocitos/metabolismo , ARN Ribosómico/biosíntesis , Ribosomas/metabolismo , Xenopus laevis/genética , Animales , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/genética , Nucléolo Celular/efectos de los fármacos , Nucléolo Celular/ultraestructura , Eritrocitos/efectos de los fármacos , Eritrocitos/ultraestructura , Femenino , Inmunohistoquímica , Hibridación in Situ , Microscopía Electrónica , Proteínas Nucleares/metabolismo , Precursores del ARN/metabolismo , ARN Ribosómico/efectos de los fármacos , ARN Nucleolar Pequeño/metabolismo , Ribosomas/efectos de los fármacos , Ribosomas/ultraestructura , Transcripción Genética/efectos de los fármacos , Transcripción Genética/fisiología , Xenopus laevis/anatomía & histología , Xenopus laevis/metabolismo
9.
EMBO J ; 20(12): 3187-96, 2001 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-11406595

RESUMEN

Initiation of transcription of protein-encoding genes by RNA polymerase II (Pol II) was thought to require transcription factor TFIID, a complex comprised of the TATA box-binding protein (TBP) and TBP-associated factors (TAF(II)s). In the presence of TBP-free TAF(II) complex (TFTC), initiation of Pol II transcription can occur in the absence of TFIID. TFTC containing the GCN5 acetyltransferase acetylates histone H3 in a nucleosomal context. We have identified a 130 kDa subunit of TFTC (SAP130) that shares homology with the large subunit of UV-damaged DNA-binding factor. TFTC preferentially binds UV-irradiated DNA, UV-damaged DNA inhibits TFTC-mediated Pol II transcription and TFTC is recruited in parallel with the nucleotide excision repair protein XP-A to UV-damaged DNA. TFTC preferentially acetylates histone H3 in nucleosomes assembled on UV-damaged DNA. In agreement with this, strong histone H3 acetylation occurs in intact cells after UV irradiation. These results suggest that the access of DNA repair machinery to lesions within chromatin may be facilitated by TFTC via covalent modification of chromatin. Thus, our experiments reveal a molecular link between DNA damage recognition and chromatin modification.


Asunto(s)
Daño del ADN , Proteínas de Unión al ADN/metabolismo , Histonas/metabolismo , Nucleosomas/metabolismo , Fosfoproteínas/metabolismo , Proteínas de Unión al ARN , Ribonucleoproteína Nuclear Pequeña U2/metabolismo , Acetilación , Secuencia de Aminoácidos , Reparación del ADN , Proteínas de Unión al ADN/genética , Células HeLa , Humanos , Datos de Secuencia Molecular , Empalme del ARN , Factores de Empalme de ARN , Moldes Genéticos , Transcripción Genética , Rayos Ultravioleta , Proteína de la Xerodermia Pigmentosa del Grupo A
10.
EMBO J ; 20(8): 2015-27, 2001 Apr 17.
Artículo en Inglés | MEDLINE | ID: mdl-11296234

RESUMEN

To date, the in vivo importance of chromatin assembly factors during development in vertebrates is unknown. Chromatin assembly factor 1 (CAF-1) represents the best biochemically characterized factor promoting chromatin assembly during DNA replication or repair in human cell-free systems. Here, we identify a Xenopus homologue of the largest subunit of CAF-1 (p150). Novel dimerization properties are found conserved in both Xenopus and human p150. A region of 36 amino acids required for p150 dimerization was identified. Deletion of this domain abolishes the ability of p150 to promote chromatin assembly in vitro. A dominant-negative interference based on these dimerization properties occurs both in vitro and in vivo. In the embryo, nuclear organization was severely affected and cell cycle progression was impaired during the rapid early cleaving stages of Xenopus development. We propose that the rapid proliferation at early developmental stages necessitates the unique properties of an assembly factor that can ensure a tight coupling between DNA replication or repair and chromatin assembly.


Asunto(s)
Cromatina/metabolismo , Proteínas Cromosómicas no Histona , Proteínas de Unión al ADN/metabolismo , Xenopus/embriología , Secuencia de Aminoácidos , Animales , Sitios de Unión , Factor 1 de Ensamblaje de la Cromatina , Dimerización , Embrión no Mamífero , Evolución Molecular , Datos de Secuencia Molecular , Nucleosomas/metabolismo , Unión Proteica , Homología de Secuencia de Aminoácido , Especificidad de la Especie , Factores de Transcripción , Técnicas del Sistema de Dos Híbridos
11.
Curr Opin Genet Dev ; 11(2): 136-41, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11250135

RESUMEN

De novo nucleosome assembly coupled to DNA replication and repair in vitro involves the histone chaperone chromatin assembly factor 1 (CAF-1). Recent studies support a model in which CAF-1 can be targeted to newly synthesized DNA through a direct interaction with proliferating cell nuclear antigen (PCNA) and can act synergistically with a newly identified histone chaperone. Insights have also been obtained into mechanisms by which this CAF-1-dependent pathway can establish a repressed chromatin state.


Asunto(s)
Proteínas Cromosómicas no Histona , Replicación del ADN , ADN/metabolismo , Nucleosomas/metabolismo , Acetilación , Animales , Factor 1 de Ensamblaje de la Cromatina , Reparación del ADN , Proteínas de Unión al ADN/metabolismo , Histonas/metabolismo , Modelos Biológicos , Chaperonas Moleculares/metabolismo , Nucleosomas/química , Antígeno Nuclear de Célula en Proliferación/metabolismo
12.
Nat Cell Biol ; 3(2): 114-20, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11175742

RESUMEN

Histone modifications might act to mark and maintain functional chromatin domains during both interphase and mitosis. Here we show that pericentric heterochromatin in mammalian cells is specifically responsive to prolonged treatment with deacetylase inhibitors. These defined regions relocate at the nuclear periphery and lose their properties of retaining HP1 (heterochromatin protein 1) proteins. Subsequent defects in chromosome segregation arise in mitosis. All these changes can reverse rapidly after drug removal. Our data point to a crucial role of histone underacetylation within pericentric heterochromatin regions for their association with HP1 proteins, their nuclear compartmentalization and their contribution to centromere function.


Asunto(s)
Núcleo Celular/efectos de los fármacos , Centrómero/metabolismo , Inhibidores Enzimáticos/farmacología , Heterocromatina/metabolismo , Inhibidores de Histona Desacetilasas , Histonas/metabolismo , Ácidos Hidroxámicos/farmacología , Animales , Western Blotting , Ciclo Celular/efectos de los fármacos , Ciclo Celular/fisiología , Línea Celular , Núcleo Celular/enzimología , Núcleo Celular/metabolismo , ADN/metabolismo , Histona Desacetilasas/metabolismo , Humanos , Hibridación Fluorescente in Situ , Ratones , Microscopía Confocal , Estructura Terciaria de Proteína , Proteínas Recombinantes/metabolismo
13.
Sci Prog ; 84(Pt 4): 267-90, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11838238

RESUMEN

Recent years have seen significant advances in the characterization and manipulation of individual molecules. The combination of single-molecule fluorescence and micromanipulation enables one to study physical and biological systems at new length scales, to unravel qualitative mechanisms, and to measure kinetic parameters that cannot be addressed by traditional biochemistry. DNA is one of the most studied biomolecules. Imaging single DNA molecules eliminates important limitations of classical techniques and provides a new method for testing polymer dynamics and DNA-protein interactions. Here we review some applications of this new approach to physical and biological problems, focusing on videomicroscopy observations of individual DNA chains extended in a shear flow. We will first describe data obtained on the stretching, relaxation and dynamics of a single tethered polymer in a shear flow, to demonstrate that the deformation of sheared tethered chains is partially governed by the thermally driven fluctuations of the chain transverse to the flow direction. Next, we will show how single-molecule videomicroscopy can be used to study in real time DNA folding into chromatin, a complex association of DNA and proteins responsible for the packaging of DNA in the nucleus of an eukaryotic cell.


Asunto(s)
ADN/ultraestructura , Microscopía Fluorescente , Microscopía por Video , Humanos , Polímeros , Mapeo de Interacción de Proteínas
14.
Proc Natl Acad Sci U S A ; 97(26): 14251-6, 2000 Dec 19.
Artículo en Inglés | MEDLINE | ID: mdl-11114182

RESUMEN

Fluorescence videomicroscopy and scanning force microscopy were used to follow, in real time, chromatin assembly on individual DNA molecules immersed in cell-free systems competent for physiological chromatin assembly. Within a few seconds, molecules are already compacted into a form exhibiting strong similarities to native chromatin fibers. In these extracts, the compaction rate is more than 100 times faster than expected from standard biochemical assays. Our data provide definite information on the forces involved (a few piconewtons) and on the reaction path. DNA compaction as a function of time revealed unique features of the assembly reaction in these extracts. They imply a sequential process with at least three steps, involving DNA wrapping as the final event. An absolute and quantitative measure of the kinetic parameters of the early steps in chromatin assembly under physiological conditions could thus be obtained.


Asunto(s)
Cromatina/metabolismo , ADN Viral/metabolismo , Nucleosomas/metabolismo , Animales , Bacteriófago lambda/genética , Extractos Celulares , Drosophila , Cinética , Microscopía de Fuerza Atómica/métodos , Microscopía por Video/métodos , Modelos Moleculares , Factores de Tiempo , Xenopus
15.
J Cell Sci ; 113 ( Pt 15): 2647-58, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10893180

RESUMEN

Chromatin is no longer considered to be a static structural framework for packaging DNA within the nucleus but is instead believed to be an interactive component of DNA metabolism. The ordered assembly of chromatin produces a nucleoprotein template capable of epigenetically regulating the expression and maintenance of the genome. Factors have been isolated from cell extracts that stimulate early steps in chromatin assembly in vitro. The function of one such factor, chromatin-assembly factor 1 (CAF-1), might extend beyond simply facilitating the progression through an individual assembly reaction to its active participation in a marking system. This marking system could be exploited at the crossroads of DNA replication and repair to monitor genome integrity and to define particular epigenetic states.


Asunto(s)
Cromatina/genética , Cromatina/metabolismo , Proteínas Cromosómicas no Histona , Reparación del ADN/fisiología , Replicación del ADN/fisiología , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Animales , Factor 1 de Ensamblaje de la Cromatina
16.
Exp Cell Res ; 256(2): 392-9, 2000 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-10772812

RESUMEN

Xenopus is a well-characterized model system for the investigation of biological processes at the molecular, cellular, and developmental level. The successful application of a rapid and reliable method for transgenic approaches in Xenopus has led to renewed interest in this system. We have explored the applicability of tetracycline-regulated gene expression, first described by Gossen and Bujard in 1992, to the Xenopus system. By optimizing conditions, tetracycline repressor induced expression of a luciferase reporter gene was readily and reproducibly achieved in both the Xenopus oocyte and developing embryo. This high level of expression was effectively abrogated by addition of low levels of tetracycline. The significance of this newly defined system for studies of chromatin dynamics and developmental processes is discussed.


Asunto(s)
Proteínas Portadoras , Regulación de la Expresión Génica , Oocitos/metabolismo , Tetraciclina/farmacología , Animales , Proteínas Bacterianas/genética , Cromatina/metabolismo , Embrión no Mamífero , Genes Reporteros , Proteína Vmw65 de Virus del Herpes Simple/genética , Técnicas In Vitro , Luciferasas/biosíntesis , Luciferasas/genética , Proteínas Represoras/genética , Xenopus
17.
J Cell Biol ; 149(2): 293-306, 2000 Apr 17.
Artículo en Inglés | MEDLINE | ID: mdl-10769023

RESUMEN

Transcription and splicing of messenger RNAs are temporally and spatially coordinated through the recruitment by RNA polymerase II of processing factors. We questioned whether RNA polymerase I plays a role in the recruitment of the ribosomal RNA (rRNA) processing machinery. During Xenopus laevis embryogenesis, recruitment of the rRNA processing machinery to the nucleolar domain occurs in two steps: two types of precursor structures called prenucleolar bodies (PNBs) form independently throughout the nucleoplasm; and components of PNBs I (fibrillarin, nucleolin, and the U3 and U8 small nucleolar RNAs) fuse to the nucleolar domain before components of PNBs II (B23/NO38). This fusion process is independent of RNA polymerase I activity, as shown by actinomycin D treatment of embryos and by the lack of detectable RNA polymerase I at ribosomal gene loci during fusion. Instead, this process is concomitant with the targeting of maternally derived pre-rRNAs to the nucleolar domain. Absence of fusion was correlated with absence of these pre-rRNAs in nuclei where RNA polymerase II and III are inhibited. Therefore, during X. laevis embryogenesis, the recruitment of the rRNA processing machinery to the nucleolar domain could be dependent on the presence of pre-rRNAs, but is independent of either zygotic RNA polymerase I transcription or the presence of RNA polymerase I itself.


Asunto(s)
Nucléolo Celular/fisiología , Embrión no Mamífero/fisiología , Regulación del Desarrollo de la Expresión Génica/fisiología , Oocitos/fisiología , ARN Ribosómico/genética , ARN Nuclear Pequeño/metabolismo , Transcripción Genética/fisiología , Xenopus laevis/embriología , Animales , Blastocisto/fisiología , Nucléolo Celular/ultraestructura , Proteínas Cromosómicas no Histona/metabolismo , Dactinomicina/farmacología , Femenino , Gástrula/fisiología , Hibridación Fluorescente in Situ , Membrana Nuclear/fisiología , Membrana Nuclear/ultraestructura , Fosfoproteínas/metabolismo , Precursores del ARN/genética , Precursores del ARN/metabolismo , ARN Nuclear Pequeño/genética , Proteínas de Unión al ARN/metabolismo , Transcripción Genética/efectos de los fármacos , Nucleolina
18.
EMBO J ; 19(5): 1023-33, 2000 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-10698943

RESUMEN

The mouse mammary tumor virus (MMTV) promoter is induced by glucocorticoid hormone. A robust hormone- and receptor-dependent activation could be reproduced in Xenopus laevis oocytes. The homogeneous response in this system allowed a detailed analysis of the transition in chromatin structure following hormone activation. This revealed two novel findings: hormone activation led to the establishment of specific translational positioning of nucleosomes despite the lack of significant positioning in the inactive state; and, in the active promoter, a subnucleosomal particle encompassing the glucocorticoid receptor (GR)-binding region was detected. The presence of only a single GR-binding site was sufficient for the structural transition to occur. Both basal promoter elements and ongoing transcription were dispensable. These data reveal a stepwise process in the transcriptional activation by glucocorticoid hormone.


Asunto(s)
Glucocorticoides/genética , Virus del Tumor Mamario del Ratón/genética , Nucleosomas/genética , Animales , Femenino , Regulación de la Expresión Génica , Glucocorticoides/metabolismo , Ratones , Nucleosomas/metabolismo , Oocitos , Regiones Promotoras Genéticas , Xenopus laevis
19.
Mol Cell Biol ; 20(4): 1206-18, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10648606

RESUMEN

Sensing DNA damage is crucial for the maintenance of genomic integrity and cell cycle progression. The participation of chromatin in these events is becoming of increasing interest. We show that the presence of single-strand breaks and gaps, formed either directly or during DNA damage processing, can trigger the propagation of nucleosomal arrays. This nucleosome assembly pathway involves the histone chaperone chromatin assembly factor 1 (CAF-1). The largest subunit (p150) of this factor interacts directly with proliferating cell nuclear antigen (PCNA), and critical regions for this interaction on both proteins have been mapped. To isolate proteins specifically recruited during DNA repair, damaged DNA linked to magnetic beads was used. The binding of both PCNA and CAF-1 to this damaged DNA was dependent on the number of DNA lesions and required ATP. Chromatin assembly linked to the repair of single-strand breaks was disrupted by depletion of PCNA from a cell-free system. This defect was rescued by complementation with recombinant PCNA, arguing for role of PCNA in mediating chromatin assembly linked to DNA repair. We discuss the importance of the PCNA-CAF-1 interaction in the context of DNA damage processing and checkpoint control.


Asunto(s)
Cromatina/metabolismo , Proteínas Cromosómicas no Histona , Daño del ADN , Proteínas de Unión al ADN/metabolismo , Antígeno Nuclear de Célula en Proliferación/metabolismo , Animales , Secuencia de Bases , Sitios de Unión/genética , Sistema Libre de Células , Cromatina/genética , Factor 1 de Ensamblaje de la Cromatina , ADN/biosíntesis , Cartilla de ADN/genética , Reparación del ADN , Proteínas de Unión al ADN/química , Proteínas de Unión al ADN/genética , Drosophila , Células HeLa , Humanos , Técnicas In Vitro , Modelos Biológicos , Modelos Moleculares , Nucleosomas/metabolismo , Antígeno Nuclear de Célula en Proliferación/genética , Conformación Proteica , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Factores de Transcripción
20.
J Cell Biol ; 147(6): 1153-66, 1999 Dec 13.
Artículo en Inglés | MEDLINE | ID: mdl-10601331

RESUMEN

To investigate the mechanisms that assure the maintenance of heterochromatin regions, we took advantage of the fact that clusters of heterochromatin DNA replicate late in S phase and are processed in discrete foci with a characteristic nuclear distribution. At the light microscopy level, within these entities, we followed DNA synthesis, histone H4 acetylation, heterochromatin protein 1 (Hp1alpha and -beta), and chromatin assembly factor 1 (CAF-1). During replication, Hp1alpha and -beta domains of concentration are stably maintained, whereas heterochromatin regions are enriched in both CAF-1 and replication-specific acetylated isoforms of histone H4 (H4Ac 5 and 12). We defined a time window of 20 min for the maintenance of this state. Furthermore, treatment with Trichostatin A (TSA), during and after replication, sustains the H4Ac 5 and 12 state in heterochromatin excluding H4Ac 8 and 16. In comparison, early replication foci, at the same level, did not display any specific enrichment in H4Ac 5 and 12. These data emphasize the specific importance for heterochromatin of the replication-associated H4 isoforms. We propose that perpetuation of heterochromatin involves self-maintenance factors, including local concentration of Hp1alpha and -beta, and that a degree of plasticity is provided by the cycle of H4 acetylation/deacetylation assisted by CAF-1.


Asunto(s)
Replicación del ADN , Heterocromatina/genética , Heterocromatina/metabolismo , Acetilación/efectos de los fármacos , Animales , Línea Celular , Factor 1 de Ensamblaje de la Cromatina , Homólogo de la Proteína Chromobox 5 , Proteínas Cromosómicas no Histona/metabolismo , ADN/biosíntesis , ADN/genética , Replicación del ADN/genética , Proteínas de Unión al ADN/metabolismo , Técnica del Anticuerpo Fluorescente , Células HeLa , Heterocromatina/química , Inhibidores de Histona Desacetilasas , Histona Desacetilasas/metabolismo , Histonas/metabolismo , Humanos , Ácidos Hidroxámicos/farmacología , Ratones , Isoformas de Proteínas/metabolismo , Fase S/genética , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...